Baseline characteristics of patients analyzed for TTF
Parameter . | R-CHOP,*no. (%) . | CHOP, no. (%) . |
|---|---|---|
| No. of patients | 362 | 268 |
| Age, y, median (range) | 56 (24-90) | 57 (21-81) |
| Age 60 years or older | 137 (38) | 103 (38) |
| Male sex | 155 (43) | 141 (53) |
| Stage IV | 248 (70) | 181 (68) |
| B-symptoms present | 143 (40) | 111 (42) |
| LDH > UNL | 104 (29) | 64 (24) |
| Hb < 12 g/dL | 74 (21) | 52 (20) |
| ECOG 2-4 | 22 (6) | 18 (7) |
| No. involved nodal areas > 4 | 221 (64) | 176 (67) |
| No. involved extranodal sites > 1 | 51 (15) | 33 (13) |
| No. FLIPI risk factors | ||
| 1 | 49 (14) | 30 (12) |
| 2 | 138 (41) | 114 (44) |
| 3 | 91 (27) | 80 (31) |
| 4 | 55 (16) | 32 (12) |
| 5 | 5 (1) | 4 (2) |
| FLIPI risk group | ||
| Low risk | 49 (14) | 30 (12) |
| Intermediate risk | 138 (41) | 114 (44) |
| High risk | 151 (45) | 116 (45) |
Parameter . | R-CHOP,*no. (%) . | CHOP, no. (%) . |
|---|---|---|
| No. of patients | 362 | 268 |
| Age, y, median (range) | 56 (24-90) | 57 (21-81) |
| Age 60 years or older | 137 (38) | 103 (38) |
| Male sex | 155 (43) | 141 (53) |
| Stage IV | 248 (70) | 181 (68) |
| B-symptoms present | 143 (40) | 111 (42) |
| LDH > UNL | 104 (29) | 64 (24) |
| Hb < 12 g/dL | 74 (21) | 52 (20) |
| ECOG 2-4 | 22 (6) | 18 (7) |
| No. involved nodal areas > 4 | 221 (64) | 176 (67) |
| No. involved extranodal sites > 1 | 51 (15) | 33 (13) |
| No. FLIPI risk factors | ||
| 1 | 49 (14) | 30 (12) |
| 2 | 138 (41) | 114 (44) |
| 3 | 91 (27) | 80 (31) |
| 4 | 55 (16) | 32 (12) |
| 5 | 5 (1) | 4 (2) |
| FLIPI risk group | ||
| Low risk | 49 (14) | 30 (12) |
| Intermediate risk | 138 (41) | 114 (44) |
| High risk | 151 (45) | 116 (45) |
UNL indicates upper normal limit
The R-CHOP cohort included randomized patients and patients assigned to R-CHOP after stop of randomization